F.D.A. Approves Drug to Treat Pain Without Opioid Effects
The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. The Food and Drug Administration approved a new medication Thursday to treat pain from an injury or surgery. It is expensive, with a list price of $15.50 per pill. But unlike opioid pain medicines, it cannot become addictive.
FDA Approves the First Non-Opioid Pain Drug in 20 Years
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and represent the first new class of pain medications in 20 years—and the first non-opioid painkiller since that class first appeared on the market in the 1980s.
The fast-growing nootropics market is set to reach $24.63 billion by 2030. These brain-boosting supplements are becoming more ...
Amneal Pharmaceuticals has received approval from the Food and Drug Administration for a dementia treatment and a drug targeting certain types of brain tumors, as well as tentative approval ...
Share on Pinterest The FDA has approved ... receptors in the brain and other areas of the central nervous system are mainly responsible for cognitive skills learning and memory.
Once every four weeks maintenance dosing may be easier for patients and care partners to continue treatment Alzheimer's ...
Verywell Health on MSN2d
New Maintenance Dosing Option for Alzheimer's Drug Leqembi Offers FlexibilityThe Food and Drug Administration (FDA) has approved a new maintenance dosing schedule for Leqembi, a monoclonal antibody ...
Two new PET radiotracers have outperformed the only current Food and Drug Administration (FDA) approved radiotracer for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback